Skip to main content
. 2016 Sep 26;29(10):467–475. doi: 10.1093/protein/gzw037

Fig. 4.

Fig. 4

TsAb3v1 and TsAb2v2 tumor cell proliferation inhibition. MDA-MB-175-VII and H322M cells were incubated for 5 days with TsAb3v1, TsAb2v2, the BsAbs HER1/IGF1R and cMetHER3 and the combination of all four parental monospecific antibodies at the reported concentrations. Cell viability was measured in a Cell Titer Glo assay and calculated as growth inhibition versus untreated control.

HHS Vulnerability Disclosure